DEBORAH L. KELLER

Overview 2016

2016

In 2016, DEBORAH L. KELLER earned a total compensation of $3.8M as Former Executive Vice President, Chief Executive Officer of Covance Drug Development at Laboratory Corp. of America Holdings.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings	$4,545
Non-Equity Incentive Plan	$637,216
Salary	$474,041
Stock Awards	$1,397,304
Other	$1,324,684
Total	$3,837,790

KELLER received $1.4M in stock awards, accounting for 36% of the total pay in 2016.

KELLER also received $4.5K of change in pension value and nonqualified deferred compensation earnings, $637.2K in non-equity incentive plan, $474K in salary and $1.3M in other compensation.

Rankings

In 2016, DEBORAH L. KELLER's compensation ranked 2,367th out of 14,075 executives tracked by ExecPay. In other words, KELLER earned more than 83.2% of executives.

Classification	Ranking	Percentile
All	2,367 out of 14,075	83rd
Division Services	387 out of 2,285	83rd
Major group Health Services	30 out of 209	86th
Industry group Medical And Dental Laboratories	5 out of 61	92nd
Industry Medical Laboratories	5 out of 61	92nd

Source: SEC filing on March 31, 2017.

Overview

KELLER's colleagues

We found five more compensation records of executives who worked with DEBORAH L. KELLER at Laboratory Corp. of America Holdings in 2016.